NCT05523466

Brief Summary

The Objective of this study is to evaluate the heart rate variability in individuals with multiple sclerosis during the applicability of Acupuncture, to analyze the behavior of the autonomic nervous system before, during, and after therapy and the changes of the condition.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable multiple-sclerosis

Timeline
Completed

Started Dec 2022

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 25, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 31, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

December 1, 2022

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2023

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
Last Updated

August 31, 2022

Status Verified

August 1, 2022

Enrollment Period

7 months

First QC Date

July 25, 2022

Last Update Submit

August 29, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Changes in the Heart Rate Variability after intervention

    the capture strap will be placed on the volunteers' chests, and the heart rate receiver (V800, Polar) will be placed on their wrists

    84 days

Study Arms (2)

Active-Sham group

EXPERIMENTAL

will start with 5 sessions (1 per week) of active acupuncture combined with HRV evaluation for 20 min. After a 2-week washout, this group will be reallocated to another 5 sessions (1 per week) of sham acupuncture for 20 min combined with HRV evaluation.

Other: Acupuncture ActiveOther: Acupuncture Sham

Sham-Active group

EXPERIMENTAL

will start an allocated 5 sessions (1 per week) of sham acupuncture combined with HRV evaluation, and after a 1-week washout period will be reallocated to 5 sessions (1 per week) of active acupuncture combined with HRV evaluation.

Other: Acupuncture ActiveOther: Acupuncture Sham

Interventions

Immediately after the placement of the Polar V800, an instrument for analyzing heart rate variability, the placing of needles at the points carefully selected for this research begins. The needling will proceed for the Active acupuncture using specific Traditional Chinese Acupuncture points: E36, BP6, F3, IG4, for 20 minutes.

Active-Sham groupSham-Active group

Immediately after the placement of the Polar V800, an instrument for analyzing heart rate variability, the placing of needles at the points carefully selected for this research begins. The needling will proceed for the Sham acupuncture using sham points (points not recognized as Acupuncture points), with the duration of 20 minutes

Active-Sham groupSham-Active group

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Individuals diagnosed with Multiple Sclerosis
  • Aged over 18 years
  • Motor and intellectual capacity to understand the evaluations
  • Light and moderate functional classification levels (EDSS scale)
  • Who accept to participate in the study through agreement with informed consent form

You may not qualify if:

  • Do not understand the evaluations
  • Cardiac diseases that impede the assessment of HRV
  • Have a cardiac pacemaker.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Multiple Sclerosis

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Celso Ferreira, Dr

    Federal University of São Paulo

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Talita D Silva, Dr

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical professor

Study Record Dates

First Submitted

July 25, 2022

First Posted

August 31, 2022

Study Start

December 1, 2022

Primary Completion

July 1, 2023

Study Completion

December 1, 2023

Last Updated

August 31, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share